Source: SYS-CON MEDIA

ImmBio: ImmunoBiology Ltd. - Product Pipeline Review - 2014

NEW YORK, Nov. 12, 2014 /PRNewswire/ -- SummaryGlobal Markets Direct's, 'ImmunoBiology Ltd. - Product Pipeline Review - 2014', provides an overview of the ImmunoBiology Ltd.'s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of ImmunoBiology Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.read more

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100



ImmBio is a Private company. ImmBio generates $1M in revenue per employee